This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is designed to reduce the risk of transmission of microorganisms from both ... (Read 67 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
Which of the following is designed to reduce the risk of transmission of microorganisms from both recognized and unrecognized sources of infection in health care facilities?
 
  A) Standard Precautions
  B) reverse isolation
  C) droplet precautions
  D) protective environment

Question 2

What is a protective isolation facility in a health care environment?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Juro

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Answer: A

Answer to Question 2

Answer: A protective isolation facility is a hospital room that is completely sterile. All food and articles are sterilized before they are taken into the patient's room. These areas are for immunocompromised patients.




JGIBBSON

  • Member
  • Posts: 538
Reply 2 on: Jun 25, 2018
Great answer, keep it coming :)


zacnyjessica

  • Member
  • Posts: 345
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library